Scalp Psoriasis: A Literature Review of Effective Therapies and Updated Recommendations for Practical Management
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Scalp Psoriasis: A Literature Review of Effective Therapies and Updated Recommendations for Practical Management
Authors
Keywords
-
Journal
Dermatology and Therapy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-25
DOI
10.1007/s13555-021-00521-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
- (2020) Abby S. Van Voorhees et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
- (2020) April W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials
- (2020) Boni Elewski et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and safety of 308-nm excimer lamp in the treatment of scalp psoriasis: a retrospective study
- (2019) Ploysyne Rattanakaemakorn et al. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE
- Efficacy and safety of mirikizumab ( LY 3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase II study
- (2019) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Real world data from the use of secukinumab in the treatment of moderate‐to‐severe psoriasis, including scalp and palmoplantar psoriasis: A 104‐week clinical study
- (2019) Natalia Rompoti et al. Dermatologic Therapy
- Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P)
- (2018) R.G. Langley et al. BRITISH JOURNAL OF DERMATOLOGY
- Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas
- (2018) Dario Kivelevitch et al. EXPERT OPINION ON PHARMACOTHERAPY
- Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study
- (2018) K. Reich et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy assessment of UVA1 and narrowband UVB for treatment of scalp psoriasis
- (2018) Jing Zhou et al. LASERS IN MEDICAL SCIENCE
- Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions
- (2018) Peter Foley et al. JAMA Dermatology
- Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis
- (2017) Steven R. Feldman et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis
- (2017) Ali Rajabi-Estarabadi et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
- (2017) Jerry Bagel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
- (2017) J. Koo et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study
- (2016) Hidemi Nakagawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)
- (2016) Kristian Reich et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)
- (2016) Phoebe Rich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)
- (2016) K. Reich et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Scalp psoriasis and biologic agents: a retrospective, comparative study from a tertiary psoriasis referral centre
- (2016) C. Fotiadou et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis
- (2015) R.G. Langley et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Update on Intralesional Steroid: Focus on Dermatoses
- (2015) Robert N. Richards JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Psoriasis prevalence among adults in the United States
- (2014) Tara D. Rachakonda et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study
- (2014) D. Thaçi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: a consensus statement from the Asia Scalp Psoriasis Study Group
- (2012) Maria Lorna F. Frez et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Targeted phototherapy using 308 nm Xecl monochromatic excimer laser for psoriasis at difficult to treat sites
- (2012) Nawaf Al-Mutairi et al. LASERS IN MEDICAL SCIENCE
- Novel stain-free lecithinized coal tar formulation for psoriasis
- (2011) Amit Bhatia et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: Results in a single community-based hospital
- (2011) Shinji NODA et al. JOURNAL OF DERMATOLOGY
- Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanercept
- (2011) Jerry Bagel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of severe scalp psoriasis: From the Medical Board of the National Psoriasis Foundation
- (2009) C. Stanley Chan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Scalp psoriasis: European consensus on grading and treatment algorithm
- (2009) JP Ortonne et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis
- (2008) T.A. Luger et al. DERMATOLOGY
- Washability and fabric‐staining properties of a novel phospholipid‐structured coal tar formulation
- (2008) Amit Bhatia et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- African American and Caucasian patients' vehicle preference for the scalp
- (2008) Emily J. Fisher et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now